Measure ID: 3.7

Measure Title: ACE Inhibitor or ARB Therapy in patients with HTN and Stage A2 or A3 Albuminuria

Eligible Patients: Adults with diagnosis of hypertension and meeting criteria for CKD with Stage A2 or A3 albuminuria

Criteria that Meets Measure: Active RX for ACEI or ARB


CKD Definitions:

Patients meet criteria for CKD if most recent eGFR is <60 and an additional eGFR more than 90 days before the most recent eGFR is also <60 OR a patient has Stage A2 or Stage 3 Albuminuria.

Stage A1 Albuminuria: Last urine albumin to creatinine ratio <30 mg/g or urine protein to creatinine ratio <150 mg/g

Stage A2 Albuminuria: Last urine albumin to creatinine ratio 30-300 mg/g or urine protein to creatinine ratio 150-500 mg/g

Stage A3 Albuminuria: Last urine albumin to creatinine ratio >300 mg/g or urine protein to creatinine ratio >500 mg/g